Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

EDI THERAPEUTICS LLC — Funding, Investors & Profile — Capbase

← All companies

Compare History

EDI THERAPEUTICS LLC

Private

Won a federal SBIR/STTR research award from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

SAM UEI: P6VEXK48QFJ8

Founded: —Source: [GOV]
Headquarters: ROCHESTER, New YorkSource: [GOV]
Headcount: 3Source: [GOV]
Stage: Seed
Sector: Healthcare

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

EDI THERAPEUTICS LLC has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $388,193 in 2024. These are non-dilutive federal research grants, not equity financing. The company is based in ROCHESTER, New York.

Funding rounds

1 rounds

SBIR Phase I award (HHS)GrantMay 2024Source: [GOV]
$388.2K
—post-money

Investors

No investors recorded yet for EDI THERAPEUTICS LLC.

Add an investor

People

Leadership

MARTIN GRAHAMPrincipal investigatorSince 2024Source: [GOV]

Acquisitions

EDI THERAPEUTICS LLC has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for EDI THERAPEUTICS LLC.

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.